Literature DB >> 21865420

Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin.

Kerry J Welsh1, Kimberly A Skrobarcek, April N Abbott, Cole T Lewis, Mark C Kruzel, Evan M Lewis, Jeanelle M Gardiner, John F Mohr, Lisa Y Armitige, Audrey Wanger.   

Abstract

The risk factors for relapse of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia after vancomycin treatment are unknown. Diversilab typing was used to classify recurrent bacteremia as relapse or reinfection. Bacteremia for >7 days and staphylococcal cassette chromosome mec element (SCCmec) type II were independently associated with relapse of MRSA bacteremia after vancomycin treatment.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21865420      PMCID： PMC3187311          DOI： 10.1128/JCM.05287-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  33 in total

1.  Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Elizabeth A Neuner; Ed Casabar; Richard Reichley; Peggy S McKinnon
Journal:  Diagn Microbiol Infect Dis       Date:  2010-07       Impact factor: 2.803

2.  Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method.

Authors:  Sarah W Satola; Monica M Farley; Karen F Anderson; Jean B Patel
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

3.  Comparison of the DiversiLab repetitive element PCR system with spa typing and pulsed-field gel electrophoresis for clonal characterization of methicillin-resistant Staphylococcus aureus.

Authors:  B Babouee; R Frei; E Schultheiss; A F Widmer; D Goldenberger
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

4.  Vancomycin: we can't get there from here.

Authors:  Nimish Patel; Manjunath P Pai; Keith A Rodvold; Ben Lomaestro; George L Drusano; Thomas P Lodise
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

5.  Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Authors:  Roopa Ganga; Kathleen Riederer; Mamta Sharma; Mohamad G Fakih; Leonard B Johnson; Stephen Shemes; Riad Khatib
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

6.  Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.

Authors:  Kerry J Welsh; April N Abbott; Evan M Lewis; Jeanelle M Gardiner; Mark C Kruzel; Cole T Lewis; John F Mohr; Audrey Wanger; Lisa Y Armitige
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

7.  Strain relatedness of meticillin-resistant Staphylococcus aureus isolates recovered from patients with repeated bacteraemia.

Authors:  C-H Liao; C-C Lai; S-Y Chen; Y-T Huang; P-R Hsueh
Journal:  Clin Microbiol Infect       Date:  2009-07-15       Impact factor: 8.067

8.  Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Authors:  T P Lodise; J Graves; A Evans; E Graffunder; M Helmecke; B M Lomaestro; K Stellrecht
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

9.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Alex Soriano; Francesc Marco; José A Martínez; Elena Pisos; Manel Almela; Veselka P Dimova; Dolores Alamo; Mar Ortega; Josefina Lopez; Josep Mensa
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies.

Authors:  Pamela A Moise; Davida S Smyth; D Ashley Robinson; Nadia El-Fawal; Carlo McCalla; George Sakoulas
Journal:  J Antimicrob Chemother       Date:  2009-03-03       Impact factor: 5.790
View more
  11 in total

1.  Characterization of methicillin-resistant Staphylococcus aureus isolates from patients with persistent or recurrent bacteremia.

Authors:  Henry Wong; Christine Watt; Sameer Elsayed; Michael John; Glen Johnson; Kevin Katz; Sigmund Krajden; Christine Lee; Tony Mazzulli; Krystyna Ostrowska; David Richardson; Baldwin Toye; Christie Vermeiren; Deborah Yamamura; Andrew E Simor
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-03       Impact factor: 2.471

2.  Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  James Truong; John J Veillette; Steve C Forland
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 3.  Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy.

Authors:  Ravina Kullar; James A McKinnell; George Sakoulas
Journal:  Clin Infect Dis       Date:  2014-07-21       Impact factor: 9.079

4.  β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.

Authors:  Thomas J Dilworth; Omar Ibrahim; Pamela Hall; Jora Sliwinski; Carla Walraven; Renée-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

5.  Targeting RNA polymerase primary σ70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid.

Authors:  Hui Bai; Guojun Sang; Yu You; Xiaoyan Xue; Ying Zhou; Zheng Hou; Jingru Meng; Xiaoxing Luo
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

6.  Absence of Protoheme IX Farnesyltransferase CtaB Causes Virulence Attenuation but Enhances Pigment Production and Persister Survival in MRSA.

Authors:  Tao Xu; Jian Han; Jia Zhang; Jiazhen Chen; Nan Wu; Wenhong Zhang; Ying Zhang
Journal:  Front Microbiol       Date:  2016-10-24       Impact factor: 5.640

7.  Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?

Authors:  Yamuna Devi Bakthavatchalam; Ravikar Ralph; Balaji Veeraraghavan; Priyanka Babu; Elakkiya Munusamy
Journal:  Infect Dis Ther       Date:  2018-11-21

8.  Identifying determinants of persistent MRSA bacteremia using mathematical modeling.

Authors:  Tsuyoshi Mikkaichi; Michael R Yeaman; Alexander Hoffmann
Journal:  PLoS Comput Biol       Date:  2019-07-11       Impact factor: 4.475

Review 9.  Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.

Authors:  Lloyd S Miller; Vance G Fowler; Sanjay K Shukla; Warren E Rose; Richard A Proctor
Journal:  FEMS Microbiol Rev       Date:  2020-01-01       Impact factor: 16.408

10.  The msaABCR Operon Regulates Persister Formation by Modulating Energy Metabolism in Staphylococcus aureus.

Authors:  Shanti Pandey; Gyan S Sahukhal; Mohamed O Elasri
Journal:  Front Microbiol       Date:  2021-04-14       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.